Beasley et al v. Janssen Research & Development, LLC et al

Filing 18

CONDITIONAL TRANSFER ORDER (CTO-156), ordering that case "Beasley et al v. Janssen Research & Development, LLC et al" C.A. No. 5:17-cv-03858, be transferred to the Eastern District of Louisiana to be part of MDL 2592. (dhmS, COURT STAFF) (Filed on 7/20/2017)

Case MDL No. 2592 Document 1318 Filed 07/19/17 Page 1 of 2

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION

MDL No. 2592

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −156)

On December 12, 2014, the Panel transferred 20 civil action(s) to the United States District Court
for the Eastern District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to
28 U.S.C. § 1407. See 65 F.Supp.3d 1402 (J.P.M.L. 2014). Since that time, 595 additional action(s)
have been transferred to the Eastern District of Louisiana. With the consent of that court, all such
actions have been assigned to the Honorable Eldon E. Fallon.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Louisiana and assigned to
Judge Fallon.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the
consent of that court, assigned to the Honorable Eldon E. Fallon.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Louisiana. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:
Jul 19, 2017

Jeffery N. Lüthi
Clerk of the Panel

Case MDL No. 2592 Document 1318 Filed 07/19/17 Page 2 of 2

IN RE: XARELTO (RIVAROXABAN)
PRODUCTS LIABILITY LITIGATION

MDL No. 2592

SCHEDULE CTO−156 − TAG−ALONG ACTIONS

DIST

DIV.

C.A.NO.

CASE CAPTION

CALIFORNIA NORTHERN
CAN

5

17−03858

Beasley et al v. Janssen Research & Development, LLC
et al

17−00716

BeRousse et al v. Janssen Research & Development,
LLC et al Opposed 7/18/17

ILLINOIS SOUTHERN
ILS

3